Filing Details

Accession Number:
0001127602-19-032767
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-14 17:21:40
Reporting Period:
2019-11-13
Accepted Time:
2019-11-14 17:21:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1732091 Birgit Girshick 251 Ballardvale Street
Wilmington MA 01887
Corporate Executive Vp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-13 1,233 $76.67 25,293 No 4 M Direct
Common Stock Acquisiton 2019-11-13 1,675 $73.70 26,968 No 4 M Direct
Common Stock Acquisiton 2019-11-13 3,492 $88.05 30,460 No 4 M Direct
Common Stock Acquisiton 2019-11-13 3,204 $109.34 33,664 No 4 M Direct
Common Stock Disposition 2019-11-13 96 $136.93 33,568 No 4 S Direct
Common Stock Disposition 2019-11-13 401 $136.94 33,167 No 4 S Direct
Common Stock Disposition 2019-11-13 350 $136.95 32,817 No 4 S Direct
Common Stock Disposition 2019-11-13 208 $136.96 32,609 No 4 S Direct
Common Stock Disposition 2019-11-13 195 $136.97 32,414 No 4 S Direct
Common Stock Disposition 2019-11-13 177 $136.98 32,237 No 4 S Direct
Common Stock Disposition 2019-11-13 192 $136.98 32,045 No 4 S Direct
Common Stock Disposition 2019-11-13 65 $136.99 31,980 No 4 S Direct
Common Stock Disposition 2019-11-13 503 $136.99 31,477 No 4 S Direct
Common Stock Disposition 2019-11-13 713 $137.00 30,764 No 4 S Direct
Common Stock Disposition 2019-11-13 77 $137.01 30,687 No 4 S Direct
Common Stock Disposition 2019-11-13 791 $137.01 29,896 No 4 S Direct
Common Stock Disposition 2019-11-13 193 $137.02 29,703 No 4 S Direct
Common Stock Disposition 2019-11-13 51 $137.03 29,652 No 4 S Direct
Common Stock Disposition 2019-11-13 52 $137.03 29,600 No 4 S Direct
Common Stock Disposition 2019-11-13 1,314 $137.05 28,286 No 4 S Direct
Common Stock Disposition 2019-11-13 100 $137.06 28,186 No 4 S Direct
Common Stock Disposition 2019-11-13 100 $137.07 28,086 No 4 S Direct
Common Stock Disposition 2019-11-13 100 $137.08 27,986 No 4 S Direct
Common Stock Disposition 2019-11-13 201 $137.09 27,785 No 4 S Direct
Common Stock Disposition 2019-11-13 134 $137.10 27,651 No 4 S Direct
Common Stock Disposition 2019-11-13 100 $137.11 27,551 No 4 S Direct
Common Stock Disposition 2019-11-13 676 $137.12 26,875 No 4 S Direct
Common Stock Disposition 2019-11-13 249 $137.13 26,626 No 4 S Direct
Common Stock Disposition 2019-11-13 767 $137.14 25,859 No 4 S Direct
Common Stock Disposition 2019-11-13 300 $137.15 25,559 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2019-11-13 1,233 $0.00 1,233 $76.67
Common Stock Stock Options (Right to Buy) Disposition 2019-11-13 1,675 $0.00 1,675 $73.70
Common Stock Stock Options (Right to Buy) Disposition 2019-11-13 3,492 $0.00 3,492 $88.05
Common Stock Stock Options (Right to Buy) Disposition 2019-11-13 3,204 $0.00 3,204 $109.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-27 2020-02-27 No 4 M Direct
1,675 2017-02-26 2021-02-26 No 4 M Direct
6,985 2018-02-24 2022-02-24 No 4 M Direct
9,614 2019-02-23 2023-02-23 No 4 M Direct
Footnotes
  1. Includes shares acquired by the Reporting Person pursuant to an exempt transaction under the Issuer's Employee Stock Purchase Plan.